September 18th, 2026Centanafadine For Comorbid ADHD and Anxiety: Talking New Data With John Kraus, MD, PhDPhase 3b data show centanafadine reduces adult ADHD and comorbid anxiety.Read more
September 9th, 2026New Phase 3 Data on Oveporexton for Narcolepsy Type 1Phase 3 NEJM data show oveporexton improves wakefulness, reduces cataplexy, and boosts quality of life in narcolepsy type 1, with manageable adverse effects.Read more
September 9th, 2026Choosing Sexual Function-Sparing MedicationsLearn why SSRIs impair sex and how bupropion, PDE5 inhibitors, buspirone, and newer agents can prevent or reverse antidepressant sexual side effects.Read more